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Each year there are two international scientific 
meetings devoted entirely to cystic fibrosis (CF); one 
North American, and one European. The Pro- 
ceedings of The Annual North American Conference 
are published as a supplement to Pediatric Pulmon- 
ology which contains short extended abstracts of 
Symposium presentations, as well as all the accepted 
abstracts for poster presentations. The European 
counterpart often has the same format, but it is 
usually available to participants only. However, at 
the 18th European CF Conference in Madrid, May 
1993, the local scientific and organizing committee 
asked a number of active participants, including all 
invited speakers, to prepare full papers on their 
presentations. This has resulted in this book which 
contains 52 articles grouped under the headings: 
Molecular Pathogenesis and Ion Transport; Genet- 
ics; Microbiology; Pseudomonas cepacia (recently 
re-named Burkholderi cepacia); Antibiotic Therapy; 
Immunology; Up-date on Therapies; Pulmonology; 
Nutrition and Gastroenterology; Reproduction; and 
Epidemiology. The latter includes some presentations 
not easily included under the other headings. 
The large majority of papers deal with clinical 
aspects of the disease which reflects the composition 
of active participants, which, by tradition, is made up 
primarily of clinicians and of scientists working 
within the fields of clinical immunology and clinical 
microbiology. It is well known that the disclosure of 
the molecular defect(s) in CF has recruited an 
increasing number of scientists working within 
molecular genetics and cell physiology into CF 
research, but the attendance of active participants 
from basic sciences is much more pronounced at the 
North American than at the European CF Confer- 
ences. In this book, only the first six contributions 
deal with these aspects which, however, include excel- 
lent up-dates on the progress towards gene therapy in 
morbidity and mortality in CF, so naturally many 
contributions (25) deal with these aspects. A number 
of these papers focus on antibiotic treatment, includ- 
ing new antimicrobial agents and different routes of 
administration. There are excellent review articles on 
the immunologic and inflammatory host reactions, 
which ultimately lead to respiratory insufficiency. 
These important aspects provide the basis for new 
approaches to treatment, using anti-inflammatory 
drugs, several of which have now been explored in 
clinical practice. An important contribution deals 
with the early clinical studies on the effects of inhaled 
human recombinant DNase, a novel treatment 
approach, which by now is in use world-wide in 
clinical practice. Others up-date the experience on 
double-lung and heart-lung transplantation for end- 
stage lung disease, written by experienced experts. 
The remaining papers deal, amongst others, with 
various aspects of nutrition, and with the liver disease 
in CF, including clinical experience with ursodeoxy- 
cholic acid treatment. The improved survival in CF 
has resulted in a growing number of child-bearing CF 
patients presenting a whole new set of problems for 
the clinician who already has to deal with this 
multi-organ, multi-facetted disease. 
The proceedings of the Annual North American 
and European CF Conferences, as well as of the 
International CF Conferences which take place less 
often, are indispensable in CF centres and this book, 
with its many carefully prepared papers and with a 
large number of excellent illustrations, is certainly of 
an improved standard compared with the usual 
European proceedings. It should thereby reach a 
wider audience and it will undoubtedly prove more 
valuable than the usual Conference proceedings as an 
easy source of specialized knowledge in day-to-day 
work in CF centres around the world. 
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